2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population...

European Journal of Cancer 2015 / 09 Vol. 51

2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies

Ma, W.W., Chung, I., Lang, I., Csõszi, T., Wenczl, M.W., Cubillo, A., Chen, J., Wong, M., Park, J.O., Kim, J.S., Rau, K.M., Melichar, B., Gallego, J., Smakal, M., Kim, J., Belanger, B., Bayever, E., A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31281-3
Date:
September, 2015
File:
PDF, 60 KB
english, 2015
Conversion to is in progress
Conversion to is failed